HKMPY fundamentals
An in-depth look to Hikma Pharmaceuticals plc. operating, investing, and financing activities
HKMPY free cash flow for H2 23 is 259.11 M USD. For 2023, HKMPY free cash flow was 364 M USD and operating cash flow was 533 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM